Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.
Looker, Helen C; Colombo, Marco; Agakov, Felix; Zeller, Tanja; Groop, Leif; Thorand, Barbara; Palmer, Colin N; Hamsten, Anders; de Faire, Ulf; Nogoceke, Everson; Livingstone, Shona J; Salomaa, Veikko; Leander, Karin; Barbarini, Nicola; Bellazzi, Riccardo; van Zuydam, Natalie; McKeigue, Paul M; Colhoun, Helen M.
; 58(6): 1363-71, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25740695
Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients.
The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: systematic review and meta-analysis.
Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus.
Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
A pilot study of an HbA1c chairside screening protocol for diabetes in patients with chronic periodontitis: the dental hygienist's role.
The usage of fasting glucose and glycated hemoglobin for the identification of unknown type 2 diabetes in high risk patients with morbid obesity.
Effects of nonsurgical periodontal treatment on glycated haemoglobin on type 2 diabetes patients (PARODIA 1 study): a randomized controlled trial in a sub-Saharan Africa population.
Comparative study of HbA and fasting plasma glucose vs the oral glucose tolerance test for diagnosis of diabetes in people with tuberculosis.
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.